课题基金 / 基金详情

Mechanism of Genetic and Phenotypic Expression in Hereditary Red Cell Membrane Disorders

Mechanism of Genetic and Phenotypic Expression in Hereditary Red Cell Membrane Disorders
遗传性红细胞膜疾病的遗传和表型表达机制
批准号:
14370311
负责人:
YAWATA Yoshihito
金额:
$6.66万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2004

项目摘要

项目成果

YAWATA Yoshihito的其他基金

相似基金

相关文献

中文摘要
翻译
(1)日本人群中的红细胞紊乱。我们研究了107个独立家庭206例患者的遗传和表型特征。自1974年我开始在这个领域的研究以来,在我的实验室研究的这些患者的总数达到了1265例,共有742个特征。(二)总结果:(1)遗传性球形细胞增多症365个家族669例(55.2%),(2)遗传性椭圆细胞增多症74个家族146例(12.0%),(3)蛋白4.2缺乏症25个家族41例,(4)遗传性口形细胞增多症66个家族107例,(5)红细胞脂质异常27个家族41例,(6)病因不明186个家族247例,(7)其他,分别进行了广泛的调查。(III)研究了红细胞膜蛋白的4个基因,即3带(EPB3)、蛋白4.2 (ELB42)、β-spectrin (SPTB)和锚蛋白(ANK 1)的DNA甲基化状态。SPTB和ANK 1的5′-CG-3′位点完全未甲基化,而ELB42和EPB3的5′-CG-3′位点重度甲基化。研究了DNA甲基化对正常人群、红细胞膜疾病患者以及红系终末分化过程中基因表达的表观遗传学控制。(四)应用分子电镜观察疾病状态下红细胞膜超微结构异常作为表型的变化。(五)这些成果的一部分作为特邀演讲在日本医学协会大会上发表(2003年4月)。
英文摘要
(I) Red cell membrane disorders in the Japanese population. We investigated genetic and phenotypic characteristics in 206 patients of 107 independent families for the recent 3 years (2002-2005). The total numbers of these patients studied at my laboratory became 1265 cases of 742 traits since 1974 when I started my research at this field.(II) As the total results, (1) hereditary spherocytosis was 669 cases of 365 families (55.2%), (2) hereditary elliptocytosis (HE) 146 cases of 74 families (12.0%), (3) protein 4.2 deficiency 41 cases of 25 families, (4) hereditary stomatocytosis (HSt) 107 cases of 66 families, (5) red cell membrane lipid abnormalities 41 cases of 27 families, (6) cases of unknown etiology 247 cases of 186 families, and (7) others, which are under extensive investigation, respectively.(III) State of DNA methylation was studied regarding the 4 genes of red cell membrane proteins, i.e., band 3 (EPB3), protein 4.2 (ELB42), β-spectrin (SPTB), and ankyrin (ANK 1). The 5'-CG-3' sites of SPTB and ANK 1 were totally unmethylated, and those of ELB42 and EPB3 were heavily methylated. Epigenetic control of gene expression by DNA methylation was investigated in normal subjects and patients with red cell membrane disorders, and during erythroid terminal differentiation.(IV) The abnormalities of ultrastructure of red cell membranes as phenotypes in disease states were investigated by molecular electron microscopy.(V) A part of these results was presented at the General Assembly Meetings of the Japan Medical Association as an invited lecture (April, 2003).
期刊论文(302)
专著(0)
科研奖励(0)
会议论文
Parvovirus B19感染症
细小病毒 B19 感染
DOI: --
发表时间: 2004
期刊: 血液フロンティア 14(12)
影响因子: --
作者: [Peters H, Martini S, Wang Y, Shimizu F, Kawachi H, Kramer S, Neumayer HH., 八幡義人]
通讯作者: 八幡義人
遺伝性球状赤血球症:膜疾患の代表格
遗传性球形红细胞增多症:代表性膜疾病
DOI: --
发表时间: 2004
期刊: 血液フロンティア 14(12)
影响因子: --
作者: [Suganami T, Mukoyama M, Mori K, Yokoi H, Koshikawa M, Sawai K, Hidaka S, Ebihara K, Tanaka T, Sugawara A, Kawachi H, Vinson C, Ogawa Y, Nakao K., 八幡義人]
通讯作者: 八幡義人
八幡義人: "血液のはたらき(単著)"講談社、東京. 178 (2004)
八幡芳人:“血液的功能(单一作者)”讲谈社,东京,178(2004)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
八幡義人: "遺伝性球状赤血球症(分担:「血液疾患データブック」)"中外医学社(印刷中). (2003)
Yoshito Yahata:“遗传性球形红细胞增多症(合著者:《血液疾病数据手册》)”Chugai Igakusha(正在出版)(2003 年)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
137
    Genotypic and Phenotypic Expressions in Red Cell Membrane Disorders
    A control mechanism of gene expression in red cell membranes
    • 批准号:
      10044329
    • 项目类别:
      Grant-in-Aid for Scientific Research (B).
    • 资助金额:
      $5.57万
    • 财政年份:
      1998
    • 负责人:
      YAWATA Yoshihito
    • 依托单位:
    A Control Mechanism of Gene and Protein Expression in Normal and Abnormal Red Cell Membranes
    • 批准号:
      09044346
    • 项目类别:
      Grant-in-Aid for international Scientific Research
    • 资助金额:
      $4.61万
    • 财政年份:
      1997
    • 负责人:
      YAWATA Yoshihito
    • 依托单位:
    Genotypic and phenotypic expressions of hereditary red cell membrane disorders
    • 批准号:
      09470235
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $8.06万
    • 财政年份:
      1997
    • 负责人:
      YAWATA Yoshihito
    • 依托单位:
    海外基金